Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
Table of Contents:; 1. Radiation Dermatitis -- 2. Hair Loss -- 3. Radiation Brain Injury -- 4. Radiation Orbital Toxicity -- 5. Ear Toxicity -- 6. Oral Mucositis -- 7. Xerostomia -- 8. Loss of Taste -- 9. Laryngeal Edema -- 10. Radiation Pneumonitis -- 11. Pericarditis -- 12. Esophagitis -- 13. Ra…
c.1 BC Cancer Agency KEL Library | Available |
Table of contents:; The evolution of lifespans and disease avoidance -- Understanding evolution at organismal and somatic levels -- The evolution of multicellularity and tumor suppression -- Mechanisms of tumor suppression -- Dominant views on the mechanisms of oncogenesis -- Adaptive oncogenesis -…
Table of Contents:; I OVERVIEW -- II DIAGNOSTIC STUDIES -- III NERVOUS SYSTEM INVOLVEMENT OF SYSTEMIC CANCERS -- IV NEUROLOGICAL COMPLICATIONS OF CANCER -- V NEUROLOGICAL COMPLICATIONS OF CANCER THERAPY -- NEUROLOGICAL COMPLICATIONS OF SPECIFIC MALIGNANCIES -- VII NEUROLOGICAL COMPLICATIONS IN LONG…
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency VAN Library Missing | Available | ||
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency SUR Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
Table of Contents:; Chapter 1 Introduction -- Chapter 2 Pelvis and abdomen -- Chapter 3 Thorax -- Chapter 4 Head and neck (Extracranial) -- Chapter 5 Intracranial -- Chapter 6 CT in Radiotherapy -- Answers to self-test questions -- Structure key
Table of Contents; 1: INTRODUCTION TO DOSING MEDICATIONS IN OBESE PATIENTS; 2: ANTIMICROBIAL DOSING IN OBESITY; 3: ANTICOAGULANTS AND ANTIPLATELETS; 4: CRITICAL CARE; 5: ANTIEPILEPTICS; 6: DOSING ANTINEOPLASTIC MEDICATIONS IN OBESE PATIENTS; 7: PEDIATRICS; 8: IMMUNOSUPPRESSION DOSING IN OBESE SOLID…
Table of Contents:; Introduction to opioid conversion calculations -- Converting among routes and formulations of the same opioid -- Converting among routes and formulations of different opioids -- Titrating opioid regimens : around the clock and to the rescue! -- Transdermal and parenteral fentany…
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency SUR Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available | ||
c.1 BC Cancer Agency CN Library | Available |
Table of Contents:; Ch.1 Background and Essentials -- Ch.2 Charged Particle Interactions with Matter -- Ch.3 Uncharged Particle Interactions with Matter -- Ch.4 Field and Dosimetric Quantities and Radiation Equilibrium: Definitions and Interrelations -- Ch.5 Elementary Aspects of the Attenuation of…
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available |
Table of Contents:; 1. Executive Summary -- 2. Introduction -- 2.1 Scope -- 2.2 Report Goals -- 2.3 Framework -- 2.4 Emergency Workers -- 3. Dosimetry Needs and Key Concepts -- 3.1 Introduction -- 3.2 What is Dosimetry? -- 3.3 Dosimetry Programs -- 3.4 Dose of Record -- 3.5 Key Concepts -- 4. Metho…
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency CN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency KEL Library | Available |
Table of Contents:; Cover -- Preface -- Contents -- Executive Summary -- 1. Introduction -- 1.1 Low Doses and Low Dose Rates -- 1.2 Use of Radiation Biology Data to Reduce the Uncertainty in Risk Estimates -- 2. General Approaches to Risk Assessment -- 2.1 Risk Assessment Process and Associated Unc…